0.2 T magnetic field inhibits angiogenesis in chick embryo chorioallantoic membrane

Marco Ruggiero1, Donald P Bottaro, Gianfranco Liguri

  • 1Department of Experimental Pathology and Oncology, University of Firenze, Firenze, Italy. biolmol@yahoo.com

Bioelectromagnetics
|June 16, 2004
PubMed

Insights

Exposure to a 0.2 T static magnetic field significantly inhibited angiogenesis, the formation of new blood vessels. This finding suggests static magnetic fields may offer a novel therapeutic strategy for diseases involving excessive blood vessel growth, such as cancer.

Area of Science:

  • Biomedical Engineering
  • Oncology
  • Physiology

Background:

  • Inhibition of angiogenesis is crucial for treating cancers and other diseases.
  • Previous research explored static magnetic fields' effects on cancer cell growth, but not angiogenesis.
  • The impact of static magnetic fields on blood vessel formation remains largely uninvestigated.

Purpose of the Study:

  • To investigate the effects of a 0.2 Tesla (T) static magnetic field on angiogenesis.
  • To determine if static magnetic fields can inhibit the process of blood vessel formation.

Main Methods:

  • The chick embryo chorioallantoic membrane (CAM) assay was used to analyze angiogenesis.
  • Eggs were exposed to a 0.2 T static magnetic field for 3 hours.
  • Angiogenic responses were induced using Prostaglandin E1 and fetal calf serum.

Main Results:

  • Exposure to a 0.2 T static magnetic field did not affect basal vascularization or embryo viability.
  • The angiogenic response induced by Prostaglandin E1 and fetal calf serum was significantly inhibited by the 0.2 T static magnetic field exposure.
  • Sham-exposed specimens showed no significant vascular reaction.

Conclusions:

  • A 0.2 T static magnetic field demonstrates an inhibitory effect on angiogenesis.
  • Static magnetic fields may represent a novel therapeutic approach for conditions characterized by excessive angiogenesis.
  • Further research could explore the clinical application of static magnetic fields in cancer treatment and other angiogenic diseases.